The research behind the headlines New to GLP-1s? Start here
GLP-1 Roundup

A practical guide to the price of care.

Compare plans

Embody review

Embody advertises bundled compounded GLP-1 injections, optional coaching and continuing remote support; payment terms deserve close attention.

We may earn a commission from partner links. Our reviews cover both partners and other providers. How we are funded

Michael Hayes’s take

The decision behind the offer.

Embody’s bundled format is easy to understand at first glance. I would put the full prepaid amount and cancellation deadline ahead of the advertised monthly figure. Its compounded injections are not FDA-approved, and its formal refund terms are substantially less flexible than “pause at any time” may sound.

See the cost and care breakdown
In this review

What you are paying for

Bundled compounded injections with optional coaching

Medication
Compounded semaglutide or tirzepatide injection; not FDA-approved
Advertised figures
$69 and $119/month; selected paid term must be confirmed
Care
Remote clinician support; optional nonclinical coaching described
Cancellation
Formal policy: at least 72 hours before billing; prepaid sums generally final
Put the full year on paper

What stands out

  • Medication and delivery presented together
  • Optional care coaching described separately from clinical care
  • Public cancellation and refund policy available

Where I would pause

  • Compounded preparations are not FDA-approved
  • Formal policy requires 72-hour cancellation notice
  • Prepaid bundles are not refunded for ordinary cancellation

Start with the actual product

Embody’s current GLP-1 storefront presents compounded semaglutide and compounded tirzepatide injections. Its own disclosure says these preparations have not been evaluated or approved by the FDA for safety, efficacy or quality. The presence of familiar brand names elsewhere on the page should not be read as evidence that its advertised vials are branded Wegovy or Zepbound.

I would treat the medication category as the first comparison decision. A prescription requirement and a licensed dispensing pharmacy are relevant facts, but neither turns a compounded preparation into an FDA-approved product. Our medication-category guide explains the difference. Request the exact preparation, dispensing pharmacy and clinical rationale before choosing a service because its opening price is lower.

A monthly figure can hide a longer purchase

The home page advertises $69 per month for the GLP-1 injection and $119 for the GLP-1/GIP injection. It also says pricing depends on the selected 4-, 12-, 24- or 52-week plan. That means the displayed monthly figure is not enough to establish what your card will be charged today or what the next renewal costs.

My comparison would have four lines: selected product, paid term, total collected now and next charge date. Do not multiply the lowest display price by twelve and call it a confirmed annual quote. Put the amount from your selected offer into the first-year cost tool, then compare the commitment alongside the total. A discounted longer bundle can be less useful than a more expensive short term if your plans change.

Does this care model fit?

Review the current offer and the terms for your selected plan.

Explore EmbodyAffiliate link. We may earn a commission.

The cancellation deadline matters more than the slogan

The formal cancellation and refund policy, dated August 25, 2026, requires a cancellation request at least 72 hours before the next billing date. It generally makes payments final, including multi-month bundles. Ordinary cancellation stops future renewal; it does not return unused prepaid months. Provider-initiated medical disqualification has a separate unused-service exception.

That is stricter than the homepage’s simplified shipment-based cancellation wording. I would ask support to reconcile the billing date, shipment processing date and cancellation deadline for the selected plan, in writing. Keep that answer with the terms you accepted. A program can have no separate membership fee and still have a consequential subscription commitment; those are different questions.

Coaching and clinical care are different services

Embody describes optional care coaching at no additional charge and expressly distinguishes coaches from clinicians. That separation is useful: motivation and accountability are different from a medical assessment. The home page also describes continuing messaging and appointments. Those are published service features, not evidence that every clinical question receives an immediate response.

I would ask which channel reaches the prescriber, how an appointment is arranged and what happens if a symptom needs an in-person assessment. The support checklist can help you make that conversation concrete. For example, a concern about hair shedding during treatment needs the treatment timeline and a clinical response, not a coaching message that assumes the cause.

Transfers need a plan before the old service ends

The official FAQ says patients transferring care must provide proof of their current prescription for clinician review. Continuing the same treatment is conditional on that review. I would establish what records are needed and who confirms the new arrangement before canceling an existing service. A lower price is not a complete handover plan.

Ask how the selected preparation is identified, who dispenses it and how refill requests are timed. Keep delivery expectations separate from a clinical decision: a fast-shipping statement begins only after the necessary steps have been completed. If there is uncertainty, record it as uncertainty instead of assuming that a previous prescription guarantees immediate acceptance.

My comparison would prioritize flexibility

LifeMD or Ro offers a different model to investigate if your priority is branded medication access and insurance coordination. SnagRx is a closer comparison for bundled compounded injections, but its own refund and billing terms need equally careful reading. Similar headline prices do not prove similar care, identical pharmacy preparation or the same commitment.

Embody is worth evaluating as a care-and-billing arrangement, with the selected terms open beside the advertisement. I would proceed only after the product, full payment and response pathway are clear. Its published support features are useful questions to verify; I would not convert them into claims of personal treatment success or superior outcomes. Our trial-reading guide explains why medication studies cannot rank telehealth services.

A different fit might be better.

Compare the reason for choosing each service, not just the name on the offer.

Based on published provider information, not personal treatment. Our review standards explain how we assess offers. A clinician must determine individual treatment suitability.

Before you go

One more option to compare.

We may earn a commission from the partner below. It is a separate provider, and eligibility and treatment decisions require its own evaluation.

Explore partner Continue to your provider